Skip to content
Opens in a new window
Cognitive Decline Biomarker, Tirofiban's Impact on Stroke, Peer Reviewers' Use of Artificial Intelligence
16 July 2026

Cognitive Decline Biomarker, Tirofiban's Impact on Stroke, Peer Reviewers' Use of Artificial Intelligence

Neurology Today in 5

About

In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about a blood test that could predict cognitive decline before pathological signs, the use of tirofiban after tenecteplase for stroke, and the role of artificial intelligence in peer review.